Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taoqishengxue Capsule for cancer-related anemia and fatigue
ChiCTR1800020244Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Mar 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Taoqishengxue in cancer-associated anemia (CRA) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Hemoglobin concentration, Red blood cell count and 5 more. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
Taoqishengxue
03
Conditions
cancer-associated anemia (CRA)
Beyond the preview
Go deeper on ChiCTR1800020244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800020244.